# Breckenridge Pharmaceutical, Inc – FDA Inspection, Feb 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/breckenridge-pharmaceutical-inc/9f0c813f-ccc6-4850-9510-0ebb41e248c9
Source feed: FDA_Inspections

> FDA inspection 1003361 of Breckenridge Pharmaceutical, Inc, February 21, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003361
- Company Name: Breckenridge Pharmaceutical, Inc
- Inspection Date: 2017-02-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1227134 - 2024-01-05
- FDA Inspection 1082461 - 2019-01-29
- FDA Inspection 898018 - 2014-09-25
- FDA Inspection 727340 - 2011-05-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-janik/2803fa51-5259-4632-93ad-c6f038bd2fd4)
- Issuing Officer

Company: https://www.keypedia.com/companies/breckenridge-pharmaceutical-inc/0dd54385-a0e5-4eb8-92f1-eeb2f161933e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c